✦ LIBER ✦
Solubility advantage of amorphous pharmaceuticals, part 3: Is maximum solubility advantage experimentally attainable and sustainable?
✍ Scribed by Sharad B. Murdande; Michael J. Pikal; Ravi M. Shanker; Robin H. Bogner
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 233 KB
- Volume
- 100
- Category
- Article
- ISSN
- 0022-3549
No coin nor oath required. For personal study only.